Edition:
United States

Cyclacel Pharmaceuticals Inc (CYCC.O)

CYCC.O on Consolidated Issue listed on NASDAQ Capital Market

5.33USD
19 Jan 2017
Change (% chg)

-- (--)
Prev Close
$5.33
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
186,497
52-wk High
$9.72
52-wk Low
$3.05

CYCC.O

Chart for CYCC.O

About

Cyclacel Pharmaceuticals, Inc. operates in the field of cell cycle biology. The Company has generated various families of anticancer drugs that act on the cell cycle, including nucleoside analogs, cyclin dependent kinase (CDK) inhibitors, polo-like kinase (PLK) inhibitors and Aurora Kinase/vascular endothelial growth factor... (more)

Overall

Beta: 3.34
Market Cap(Mil.): $22.66
Shares Outstanding(Mil.): 4.25
Dividend: --
Yield (%): --

Financials

  CYCC.O Industry Sector
P/E (TTM): -- 45.12 30.76
EPS (TTM): -4.08 -- --
ROI: -63.42 -1.32 14.89
ROE: -65.01 -0.98 16.30

BRIEF-Intra-Cellular Therapies' unit enters into supply agreement with Siegfried Evionnaz

* Intra-Cellular Therapies Inc- on January 4, 2017, co's unit entered into a supply agreement with Siegfried Evionnaz SA- SEC filing Source: (http://bit.ly/2jALlxx) Further company coverage:

Jan 10 2017

BRIEF-Cyclacel Pharmaceuticals Q3 loss per share $0.86

* Cyclacel pharmaceuticals reports 3rd quarter 2016 financial results

Nov 14 2016

BRIEF-Intra-Cellular Therapies reports Q3 financial results

* Intra-Cellular Therapies reports third quarter 2016 financial results and provides corporate update

Nov 09 2016

BRIEF-Tang Capital reports 9.5 pct stake in Cyclacel Pharmaceuticals

Source text - http://bit.ly/2cDs1vi Further company coverage:

Sep 16 2016

BRIEF-Intra-Cellular Therapies files for mixed shelf of up to $350 mln

* Files for mixed shelf of up to $350 million - SEC filing Source: (http://bit.ly/2c1aXOy) Further company coverage:

Sep 02 2016

BRIEF-Intra-Cellular Therapies reported Q2 EPS ($0.71)

* Cellular Therapies reports second quarter 2016 financial results and provides corporate update

Aug 04 2016

Competitors

Earnings vs. Estimates